Sporadic Creutzfeldt-Jakob Disease Initially Presenting With Posterior Reversible Encephalopathy Syndrome: A Case Report.
Journal
The neurologist
ISSN: 2331-2637
Titre abrégé: Neurologist
Pays: United States
ID NLM: 9503763
Informations de publication
Date de publication:
02 Aug 2023
02 Aug 2023
Historique:
medline:
16
8
2023
pubmed:
16
8
2023
entrez:
15
8
2023
Statut:
aheadofprint
Résumé
Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal neurodegenerative condition caused by prion proteins. Cortical and subcortical diffusion-weighted imaging restriction on magnetic resonance imaging (MRI) is associated with sCJD. Posterior reversible encephalopathy syndrome (PRES) results from impaired vessel autoregulation due to an identifiable trigger, which is associated with subcortical fluid-attenuated inversion recovery changes on MRI. We report a case of sCJD initially presenting with PRES. A 70-year-old woman presented to an outside hospital with progressive confusion and difficulty in managing activities of daily living. Initial examination revealed stuporous mental state and stimulus-induced myoclonus. MRI revealed bilateral subcortical occipital lobe T2-fluid-attenuated inversion recovery hyperintensities without contrast enhancement suggestive of PRES. Electroencephalogram (EEG) revealed frequent generalized periodic discharges meeting criteria for nonconvulsive status epilepticus. Clinical examination and EEG did not improve despite escalating antiseizure medications. Initial lumbar puncture was unremarkable. She was transferred to our hospital with a presumptive diagnosis of PRES, although there was no clear trigger. Continuous EEG revealed ongoing generalized periodic discharges with myoclonic activity meeting criteria for myoclonic seizures that were refractory to multiple antiseizure medications. Repeat MRI showed resolution of PRES but revealed subtle diffuse cortical diffusion-weighted imaging restriction. Repeat lumbar puncture was performed and 14-3-3 and real-time quaking-induced conversion returned positive, confirming sCJD. This case reports highlights that sCJD can present with neuroimaging consistent with PRES. The diagnosis of sCJD should be considered in patients with PRES who continue to show neurological decline despite optimal management and radiographic improvement of PRES on MRI. Further research is needed to identify a pathophysiological relationship between these clinical phenotypes.
Identifiants
pubmed: 37582680
doi: 10.1097/NRL.0000000000000519
pii: 00127893-990000000-00088
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Geschwind MD. Prion diseases. Continuum (Minneap Minn). 2015;21:1612–1638.
Hermann P, Laux M, Glatzel M, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology. 2018;91:e331–e338.
Rhoads DD, Wrona A, Foutz A, et al. Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology. 2020;95:e1017–e1026.
Shir D, Lazar EB, Graff-Radford J, et al. Analysis of clinical features, diagnostic tests, and biomarkers in patients with suspected Creutzfeldt-Jakob Disease, 2014-2021. JAMA Netw Open. 2022;5:e2225098.
World Health Organization (WHO). WHO manual for surveillance of human transmissible spongiform encephalopathies including variant Creutzfeldt-Jakob disease; 2003. Accessed January 5, 2023. https://www.who.int/bloodproducts/TSE-manual2003.pdf
Centers for Disease Control and Prevention (CDC). CDC’s diagnostic criteria for Creutzfeldt-Jakob disease (CJD); 2018. Accessed January 5, 2023. https://www.cdc.gov/prions/cjd/diagnostic-criteria.html
Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264:1608–1616.
Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85:427–432.
Feske SK. Posterior reversible encephalopathy syndrome: a review. Semin Neurol. 2011;31:202–215.
Koperek O, Kovács GG, Ritchie D, et al. Disease-associated prion protein in vessel walls. Am J Pathol. 2002;161:1979–1984.
Llorens F, López-González I, Thüne K, et al. Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt-Jakob disease. Front Aging Neurosci. 2014;6:198.
Dirzius E, Balnyte R, Steibliene V, et al. Sporadic Creutzfeldt-Jakob disease with unusual initial presentation as posterior reversible encephalopathy syndrome: a case report. BMC Neurol. 2016;16:234.
Krüger S, Larsen J, Schaumberg J. Sporadische Creutzfeldt-Jakob-Erkrankung imitiert posteriores reversibles Enzephalopathie-Syndrom [Sporadic Creutzfeldt-Jakob disease imitates posterior reversible encephalopathy syndrome]. Nervenarzt. 2019;90:618–622.
Bittar J, Joshi P, Genova J, et al. Creutzfeldt-Jakob disease presenting as posterior reversible encephalopathy syndrome. Cureus. 2020;12:e7211.